1. Home
  2. SOLS vs GKOS Comparison

SOLS vs GKOS Comparison

Compare SOLS & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Solstice Advanced Materials Inc.

SOLS

Solstice Advanced Materials Inc.

SELL

Current Price

$60.15

Market Cap

9.2B

Sector

Industrials

ML Signal

SELL

Logo Glaukos Corporation

GKOS

Glaukos Corporation

SELL

Current Price

$165.64

Market Cap

9.7B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SOLS
GKOS
Founded
2025
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Aerospace
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.2B
9.7B
IPO Year
2025
2015

Fundamental Metrics

Financial Performance
Metric
SOLS
GKOS
Price
$60.15
$165.64
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
14
Target Price
$78.60
★ $199.31
AVG Volume (30 Days)
★ 1.9M
927.3K
Earning Date
11-04-2026
10-28-2026
Dividend Yield
★ 0.50%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 1.28
N/A
Revenue
★ $3,886,000,000.00
$507,442,000.00
Revenue This Year
$7.28
$36.30
Revenue Next Year
$5.75
$23.25
P/E Ratio
$46.75
★ N/A
Revenue Growth
3.08
★ 32.33
52 Week Low
$40.43
$73.16
52 Week High
$90.80
$191.62

Technical Indicators

Market Signals
Indicator
SOLS
GKOS
Relative Strength Index (RSI) 52.25 50.94
Support Level $55.24 $147.72
Resistance Level $63.65 $186.99
Average True Range (ATR) 1.89 7.22
MACD 0.29 0.94
Stochastic Oscillator 76.58 72.38

Price Performance

Historical Comparison
SOLS
GKOS

About SOLS Solstice Advanced Materials Inc.

Solstice Advanced Materials is a diversified specialty chemicals company created in late 2025 after being spun off from Honeywell. It sells chemicals and materials to a wide range of end markets. Its largest product category is refrigerants used in heating, ventilation and air conditioning systems, and autos, where Solstice sells low global warming potential refrigerants. The company also sells materials used for building and construction, semiconductor production, healthcare packaging, and defense. Additionally, Solstice runs the only US uranium conversion business currently in operation.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: